U.S. Supreme Court: Federal Trade Commission v. Watson Pharmaceuticals et al [GPA amicus brief]
MLex Summary: The Generic Pharmaceutical Association has filed a brief with the Supreme Court, urging the justices to reject the U.S. Federal Trade Commission's argument that 'pay for delay' agreements are presumptively unlawful.See...To view the full article, register now.
Already a subscriber? Click here to view full article